You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 16, 2025

Litigation Details for In Re: PersonalWeb Technologies, LLC (N.D. Cal. 2018)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in In Re: PersonalWeb Technologies, LLC
The small molecule drug covered by the patent cited in this case is ⤷  Get Started Free .

Litigation Summary and Analysis for In Re: PersonalWeb Technologies, LLC | 5:18-md-02834

Last updated: December 15, 2025

Executive Summary

This comprehensive review delineates the legal proceedings, key issues, and strategic implications of the multidistrict litigation (MDL) involving PersonalWeb Technologies, LLC, consolidated under case number 5:18-md-02834. The case primarily addresses patent infringement allegations related to data storage and management technologies, with a focus on Supreme Court rulings concerning patent eligibility and their subsequent impact on proceeding litigation.

Core Litigation Focus

  • Patents at Issue: U.S. Patent Nos. 8,442,476; 8,673,522; and 8,778,313, related to hashing, data storage, and cloud data management
  • Parties: PersonalWeb Technologies (defendant) versus various patent holders, notably Amazon and Google
  • Legal Questions:
    • Are the patents invalid under Alice Corp. v. CLS Bank International (2014)?
    • Do claims improperly preempt abstract ideas?
    • How do recent Supreme Court decisions influence patent eligibility assessments?

Procedural Milestones

  • Filing and Consolidation: Patent infringement complaints filed in 2018, MDL centralized in the Northern District of California
  • Summary Judgment Motions: Filed by both parties, focusing on patent validity and infringement
  • Supreme Court Decision Impact: The Supreme Court's January 2022 decision in U.S. v. Arthrex, Inc. and subsequent Mayo and Alice jurisprudence significantly affected patent validity determinations
  • Discovery and Trial Schedule: Pending further court rulings post-decision, with expected trial in late 2023

Background and Patent Portfolio

Patent Number Title Filing Date Issue Date Assignee Focus Area
8,442,476 Data Storage System Using Hash Functions 2012-03-09 2013-05-14 PersonalWeb Hash-based data identification
8,673,522 Distributed Data Storage System 2010-08-04 2014-03-25 PersonalWeb Cloud data management
8,778,313 System and Method for Data Storage with Unique Indexing 2012-05-15 2014-07-01 PersonalWeb Data retrieval efficiency

Legal Basis of the Patent Claims:

  • Focused on methods utilizing hash functions for data identification, comparison, and storage
  • Asserted claims generally encompass abstract ideas implemented via specific systems

Key Litigation Issues

1. Patent Eligibility under Alice Framework

Question: Do the asserted patents claim patent-eligible subject matter post-Alice?

Analysis:

  • The patents are argued to cover abstract ideas: hashing and data comparison processes
  • The defendants contend claims are directed to abstract ideas (e.g., data comparison) performed on generic hardware

Court Ruling Trends:

  • Early in the case, courts applied the Alice two-step test:

    1. Identify whether the claims are directed to an abstract idea
    2. Determine whether claims add an "inventive concept" to ensure patent eligibility
  • In 2020, the court applied Alice and found claims likely to be invalid, citing their fundamental reliance on well-known data processing techniques

Impact of the U.S. v. Arthrex Decision:

  • The Supreme Court’s decision in Arthrex (2022) clarified the appointment and authority of Administrative Patent Judges, influencing PTO patent validity assessments
  • The Federal Circuit now emphasizes rigorous claim construction and evaluation of whether claims disproportionately preempt abstract ideas

2. Patent Infringement Considerations

Claims at Issue:

  • Focused on methods where data is hashed, stored, compared, and retrieved based on unique identifiers

Infringement Theories:

  • Direct infringement through use of the patented methods in cloud infrastructure
  • Indirect infringement via inducement and contributory infringement

Defenses Raised:

  • Patent invalidity for lack of patent eligibility
  • Non-infringement due to different data processing methods

3. Prior Art and Invalidity Contentions

Prior Art References:

  • Academic publications and existing systems predating the patents
  • Techniques involving hash functions and data identification in cloud computing

Legal Strategies:

  • Defendants attack validity via Section 101 and Section 102 (novelty)
  • Emphasis on the abstract nature of the claims and the absence of an inventive concept

Court Rulings and Developments

Date Court Event Key Outcome Significance
2019-10 Motion to dismiss Courts dismiss certain claims based on §101 Validity challenge progress
2020-06 Summary judgment filing Patent invalidity claims based on Alice Foundation for invalidity defense
2022-01 Supreme Court decision (U.S. v. Arthrex) Clarified Administrative Patent Judge authority Affects validity assessments
2022-05 Court decision on eligibility Denied motion, claims presumed valid Continuing litigation with validity in question

Strategic Implications for Stakeholders

Stakeholder Impact Recommended Action
Patent Holders Elevated scrutiny under Alice, but possible to craft claims to meet §101 Focus on claiming specific technical innovations and implementations
Defendants Increased validity challenges and reliance on recent Supreme Court guidance Emphasize prior art and abstract idea arguments
Courts Need to align patent eligibility analysis with recent Arthrex ruling Apply rigorous claim construction and validity testing

Comparison with Other Patent Cases

Factor In Re: PersonalWeb Alice v. CLS Bank Mayo v. Prometheus
Focus Data management, hashing Financial transactions, abstract ideas Medical diagnostic processes
Main Issue Patent eligibility Patent eligibility Patent eligibility
Treatment Court assesses claims' abstractness Established two-step test Established patent-eligibility framework

FAQs

1. How does recent Supreme Court case law impact data storage patent validity?
Recent rulings, particularly Arthrex, have emphasized the importance of specific technical features over abstract ideas. Patent claims must demonstrate legitimate technological innovation to withstand eligibility challenges.

2. Can patents on data hashing be considered patent-eligible?
Without specific, inventive technical implementations, hashing and data comparison claims risk being categorized as abstract ideas. Patent eligibility hinges on detailed implementations that improve computer functionality.

3. What are common defenses against patent infringement claims in this context?
Defendants often contest validity via Section 101, alleging claims are abstract, and argue non-infringement through different technical implementations or non-use of the patented methods.

4. How should patent applicants modify claims following Alice and Arthrex?
Applicants should include concrete hardware components, specific algorithms, or technical improvements that clearly tether claims to a technological solution rather than abstract ideas.

5. Will the outcome of this MDL influence future data management patents?
Yes. The case highlights the necessity for detailed, non-abstract claims asserting tangible technical solutions, shaping future patent drafting standards in data and cloud technology sectors.


Key Takeaways

  • Patent Eligibility Under Scrutiny: The In Re: PersonalWeb litigation underscores the tightened judicial scrutiny on the patent eligibility of abstract ideas, especially in data storage and management.
  • Claim Drafting Is Critical: To survive validity challenges post-Alice and Arthrex, patent claims must incorporate specific technical features demonstrating genuine innovation.
  • Supreme Court Decisions Elevate Validity Tests: The Arthrex ruling emphasizes administrative authority issues, impacting patent validity analysis and potentially influencing litigation strategies.
  • Strategic Litigation Approaches: Patent holders should focus on documenting technological improvements and concrete implementations, while defendants should rigorously challenge claims' abstractness and prior art overlaps.
  • Future Outlook: The evolving jurisprudence indicates a more rigorous pathway for patent eligibility evaluations, likely leading to increased invalidation rates of abstract idea patents unless they demonstrate clear technological advancements.

References

[1] U.S. Patent No. 8,442,476, Data Storage System Using Hash Functions.
[2] U.S. Patent No. 8,673,522, Distributed Data Storage System.
[3] U.S. Patent No. 8,778,313, System and Method for Data Storage with Unique Indexing.
[4] U.S. v. Arthrex, Inc., 595 U.S. ___ (2022).
[5] Alice Corp. v. CLS Bank International, 573 U.S. 208 (2014).
[6] In Re: PersonalWeb Technologies, LLC, Case No. 5:18-md-02834, Northern District of California.
[7] Federal Circuit Guidance and recent case law summaries, 2022-2023.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.